Monthly Recurring Revenue (MRR)HealthTechSeed

Monthly Recurring Revenue (MRR) for HealthTech at Seed

2026 data · Sample size: 198 · Source: Lenny Rachitsky Newsletter Benchmarks

25th %ile

$117,700

Median

$172,752

75th %ile

$254,165

90th %ile

$315,577

▲Trending up year-over-year

About This Metric

Predictable monthly revenue from all active subscriptions, normalized to a monthly figure.

Sum of all monthly subscription revenue

Higher is better · Unit: currency

How to Improve

Focus on net‑new customer acquisition while reducing churn to drive MRR growth. Implement expansion revenue programs that increase average revenue per customer over time. Optimize pricing strategy to capture more value with tiered or usage‑based models. Accelerate sales cycle velocity by improving lead qualification and demo conversion. Launch new product lines that create cross‑sell opportunities within existing customer base.

Ehsan's Analysis

HealthTech MRR growth is slow but extraordinarily sticky. A health system that signs a $50K/month contract is signing for 3-5 years minimum, with renewal rates above 90%. This creates predictable but lumpy MRR: zero revenue during the 12-month sales cycle, then a step-function increase that remains flat for years. HealthTech founders misread this as "slow growth" when it is actually "lumpy growth with near-permanent revenue." The MRR planning approach: model revenue as discrete contract wins (each a step function) rather than smooth curves. A healthtech company adding 2-3 hospital system contracts per year might grow MRR from $50K to $200K in a single month, then plateau until the next win. Investors who understand healthcare value this pattern. Those who compare it to SaaS's month-over-month smooth curves will penalize you unfairly.

Ehsan Jahandarpour

AI Growth Strategist & Fractional CMO

Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council

Frequently Asked Questions

What is a good Monthly Recurring Revenue (MRR) for HealthTech companies at Seed stage?

The median Monthly Recurring Revenue (MRR) for HealthTech companies at the Seed stage is $172,752. Top‑quartile companies (75th percentile) significantly outperform this baseline. The most important factor is consistent improvement over time rather than hitting any single target number.

How does Monthly Recurring Revenue (MRR) differ by company stage in HealthTech?

Monthly Recurring Revenue (MRR) typically increases as HealthTech companies mature from seed through growth stage. Earlier‑stage companies should benchmark against stage‑appropriate peers rather than comparing themselves to mature companies.

How often should HealthTech companies measure Monthly Recurring Revenue (MRR)?

HealthTech companies at the Seed stage should track Monthly Recurring Revenue (MRR) monthly at minimum, weekly if possible. Set up automated dashboards and alerts for significant deviations from your baseline.

What factors most impact Monthly Recurring Revenue (MRR) in the HealthTech sector?

In HealthTech, the primary factors impacting Monthly Recurring Revenue (MRR) include product‑market fit maturity, competitive landscape intensity, customer segmentation strategy, pricing optimization, and operational efficiency. Seed‑stage companies should focus on the one or two highest‑leverage factors rather than trying to optimize everything simultaneously.

How does Monthly Recurring Revenue (MRR) for HealthTech compare to cross‑industry benchmarks?

HealthTech Monthly Recurring Revenue (MRR) benchmarks can differ significantly from cross‑industry averages due to factors specific to the HealthTech vertical including customer acquisition dynamics, competitive intensity, and typical deal sizes. Always compare against industry‑specific benchmarks rather than broad averages for meaningful insights.